Archives of Cardiovascular Imaging

Case Report

27/2/2023

Fatal Expanding Thoracoabdominal Aneurysm in Known but Mistreated Behcet’s Disease in a Young Patient

Bakkali Tarik, Hamzi Mohamed Amine, Lekhel Brahim, Sefiani Yasser, Mesnaoui Abbes, Bensaid Younes

Case Presentation: A 23-year-old man was diagnosed with Behcet’s disease, as revealed by a carotid aneurysm, and was treated with a prosthetic graft reconstruction as well as immunosuppressive therapy. The patient was lost to follow-up. He stopped the medications of his own will 1 month after his discharge from the hospital. Two years later, he presented with chest pain of 1 week’s duration. A large aneurysm involving a long aorta segment from the sinus of Valsalva to the abdominal aorta above the renal arteries was identified by computed tomography angiography. Unfortunately, the patient died despite immunosuppressive therapy and before any surgical or endovascular intervention could be performed.

Brief Report

27/2/2023

Echocardiographic Evaluation of the Effects of High-Intensity Interval Training on Cardiac Morphology and Function

Arash Saadatnia, Khosrow Ebrahim, Amir Rashidlamir

Patients and Methods: Twenty-two young men (age = 23.34 ± 2.56 years, weight = 72.47 ± 12.01 kg, and height = 174.10 ± 5.75 cm) were recruited and randomly assigned into control (n = 10) and HIIT (n = 12) groups. Echocardiography was used to evaluate left ventricular mass (LVM), end-systolic volume (ESV), end-diastolic volume (EDV), interventricular septal wall thickness (IVSWT), stroke volume, and ejection fraction (EF). Also, the Bruce treadmill test was employed to estimate VO_2max.

Research Article

25/2/2023

Evaluation of Tricuspid Regurgitant Jet Velocity in Thalassemia Patients with Splenectomy

Marzieh Nikparvar, Nehzat Akiash, Nader Fayazi, Sepideh Fouladi, Fatemeh Jafary, Mahboubeh Pazoki

Research Article

28/5/2023

The Effects of Curcumin on Left Ventricular Function in Patients with Chronic Renal Failure

Arezoo Khosravi, Hesam Hashemi, Maryam Moshkani Farahani, Mitra Dolatkhah, Zohreh Rostami, Younes Panahi

Methods: This study is a double-blind, placebo-controlled trial conducted on 35 patients with chronic renal failure undergoing dialysis in the dialysis center of Baqiyatallah hospital. The patients were randomly divided into 2 groups: the curcumin group (n = 20) and the control group (n = 15). The curcumin group received curcumin capsules at a dose of 500 mg every 8 hours for 6 weeks (1500 mg/d) and the control group received a placebo for 6 weeks at the same dose. Echocardiography was done before the use of the drug and once after the 6th week. Also, the ejection fraction (EF), representing LV function and size, was measured in both groups.

Results: The mean age was 44.2 ± 13.4 years for the curcumin group and 45.4 ± 6.2 years for the placebo group. The study population comprised 22 male and 13 female patients. There were no significant differences regarding demographic variables such as age, sex, and body mass index between the 2 groups. In the curcumin group, LVEF based on the volume changed from 50.6% ± 7.1% to 51.5% ± 6.8% (P = 0.130). In the curcumin group, LVEF based on the diameter changed from 51.8% ± 3.8% to 52.4% ± 3.5% (P = 0.112). The changes in the mean EF before and after the intervention were not significant in each group. The EF, based on ventricular volume and diameter, was not significantly different between the 2 groups. In addition, the pulmonary artery pressure mean in both groups did not significantly change after the intervention (P > 0.05).

Letter

27/2/2023

Hypertrophic Obstructive Cardiomyopathy Diagnosed During Regadenoson Stress Test

Salahuddin Siddiqui, Khalid J Manzar

Letter

27/2/2023

Stress Echocardiography in Prosthetic Heart Valves

Anita Sadeghpour, Azin Alizadehasl

Archives of Cardiovascular Imaging: Feb 2016, 4 (1), 6 articles.